Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Tatva Chintan Pharma Chem has informed that the company will be meeting with Investor ‘Anand Rathi’ on 26 June 2024 on a One on One basis. The Company will be referring to publicly available information for discussions during interaction in the meeting. No confidential / unpublished price sensitive information (UPSI) will be shared during the meeting. The above information shall be made available on the website of the Company at www.tatvachintan.com.
The above information is a part of company’s filings submitted to BSE.
